维普期刊资源整合服务平台（V6.5）

28篇 您的检索式：作者名="Borchmann"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Phase 1 trial of the novel bispecific molecule H22xKi- 4 in patients with refractory Hodgkin lymphoma显示文摘	Borchmann P Schnell R Fuss I	2002	Blood2002，100，9：	1
2	Immunotherapy of Hodgkins lymphoma显示文摘	BORCHMANN P SCHNELL R ENGERT A	2005	Haemstol Suppl2005，5，66：	1
3	Die Lagriiden-Fauna der Philippinen显示文摘	BORCHMANN F	1930	PhilippineJournal of Science1930，41，：	1
4	New drugs in the treatment of Hodgkin's disease 显示文摘	BORCHMANN P SCHNELL R DIEHL V	1998	Ann Oncol1998，9，5：	1
5	Targeted BEACOPP variants in patients with newly diagnosed advanced stage classical Hodgkin lymphoma:interim results of a randomized phase Ⅱ study显示文摘	Borchmann P Eichenauer DA Pluetschow A	2013	Blood2013，122，：	1
6	Eight cycles of escalated-dose BEACOPP compared with four cycles of escala- ted-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with ad- vance&stage hodgkin's lymphoma: final analysis of the HD12 trial of the German Hodgkin Study Group显示文摘	Borchmann P Haverkamp H Diehl V	2011	J Clin Oncol2011，29，32：	1
7	Early intensification treatment approach in advanced-stage Hodgkin lymphoma 显示文摘	Borchmann P	2014	Hematol Oncol Clin North Am2014，28，1：	1
8	Fludarabine in combination with alemtuzumab is effective and feasible in patients with relapsed or refractory B-cell chronic lymphocytic leukemia:results of a phase Ⅱ trial显示文摘	Elter T Borchmann P Schulz H	2005	J Clin Oncol2005，23，28：	1
9	Eight cycles of escalated- dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP withor without radio- therapy in patients with advanced-stage hodgkin' s lymphoma: final a- nalysis of the HD12 trial of the German I-Iodgkin Stud Group 显示文摘	Borchmann P Haverkamp H Diehl V	2011	J Clin Oncol2011，29，32：	1
10	Die Lagriinae (Unterfamilie der Lagriidae)显示文摘	Borchmann F	1915	Archivfur Naturgeschichte1915，81，：	1
11	Corporaal in Ost-Sumatra gesammelten Lagriiden, Alleculiden, Meloiden und Othniiiden显示文摘	Borchmann F Herrn J B	1929	Tijdschrift voorEntomologie1929，71，：	1
12	Dose-escalation with BEACOPP escalated is superior to ABVD in the combined-modality treatment of early unfavorable Hodgkin lymphoma:final analysis of the German Hodgkin Study Group HD14 trial显示文摘	Engert A Borchmann P Pluetschow A	2010	Blood2010，116，：	1
13	Clinical evaluation of ricin A-chain immunotoxins in patients with Hodgkin's lymphoma显示文摘	Schnell R Borchmann P Staak JO	2003	Ann Oncol2003，14，5：	1
14	Fludarabine in combination with alemtuzumab is effective and feasible in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: results of a phase II trial显示文摘	ELTER T BORCHMANN P SCHULZ H	2005	J Clin Oncol2005，23，28：	1
15	Immunotherapy of Hodgkin' s lymphoma显示文摘	Borchmann P Schnell R Engert A	2005	Eur J Haematol2005，75，66：	1
16	phase H study of the new aza-anthracenidone,BBR2778,in patients with relapsed aggressive non-Hodgkin, slymphomas显示文摘	BORCHMANN P MORSCHHAUSER F PARRY A etal	2003	Haematolgia2003，88，：	1
17	Clinical evaluation of riein Achain immunotoxins in patients with Hodgkin' s lymphoma 显示文摘	Schnell R Borchmann P Staak J O	2003	Ann Oncol2003，14，5：	1
18	Idarubicin:a brief overview on pharmacology and clinical use显示文摘	Borchmann P Hübel K Schnell R		0，，：	1
19	Xylobiose and xylooligomers显示文摘	PULS J BORCHMANN A GOTTSCHALK D	1988	Method Enzymol1988，160，：	1
20	Dose-intensified combined followed by 2 cycles of ABVD and involvad field radiotherapy (IF-RT) is superior to 4 cycles of ABVD and IFRT in patients with early unfavouable Hodgkin lymphoma (HL):an analysis of the German Hodgkin Study Group (GHSG) HD14 Trial显示文摘	Borchmann P Engert A Pluetschow A	2008	Blood2008，112，11：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示